Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Morgantown › NPI 1184719874
Physician

Hammad, Ghayth

Hammad, Ghayth was paid $3.01M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.

33Billing provider infoHAMMAD, GHAYTH
MORGANTOWN, KY 42261
33aNPI1184719874assigned 10/04/2006
28Total paid$3.01M
24GClaims207,121
24DCodes billed86
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Internal Medicine Physician providers in Kentucky

Rank by total paid#9 of 231
Median peer was paid$77K
This provider vs. median39×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201823,907$579K
201921,201$512K
202020,870$469K
202133,516$451K
202238,664$345K
202334,832$308K
2024incomplete34,131$350K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 33% 32,560 23,498 $986K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 6.1% 2,184 1,949 $183K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.9% 3,951 3,316 $148K
99232 Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity 4.6% 7,507 2,349 $140K
J0696 Injection, ceftriaxone sodium, per 250 mg 4.5% 3,984 3,311 $136K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4.4% 8,093 6,307 $132K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 4.2% 1,862 1,665 $127K
99497 4.1% 2,803 2,468 $122K
99223 Prolong inpt eval add15 m 3.9% 2,093 1,718 $117K
71046 Radiologic examination, chest; 2 views 3.3% 6,069 5,102 $100K
99238 Hospital discharge day management, 30 minutes or less 3.1% 3,350 2,773 $93K
99222 Initial hospital care, per day, moderate complexity 2.0% 1,131 1,005 $61K
74 more codes
99231 Subsequent hospital care, per day, straightforward or low complexity 1.8% 4,408 $56K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1.6% 1,522 $48K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.5% 604 $46K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.5% 3,709 $46K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.5% 3,753 $45K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.3% 612 $39K
74018 1.1% 2,147 $34K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.0% 424 $31K
93000 1.0% 2,200 $31K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 702 $25K
99442 <1% 856 $23K
72100 <1% 1,055 $22K
99406 <1% 2,384 $19K
99307 <1% 3,030 $18K
93922 <1% 706 $18K
99203 Doctor's office visit, new patient (routine) <1% 274 $17K
80305 <1% 1,936 $17K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,045 $15K
90756 <1% 650 $12K
70210 <1% 548 $10K
76775 <1% 323 $9K
72040 <1% 432 $8K
90674 <1% 486 $8K
77080 <1% 119 $7K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,149 $7K
99215 Doctor's office visit, returning patient (complex) <1% 86 $5K
82962 <1% 2,161 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 225 $4K
92250 <1% 171 $4K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 668 $4K
73560 <1% 209 $4K
94060 <1% 109 $4K
G0444 Annual depression screening, 5 to 15 minutes <1% 2,388 $4K
71045 Radiologic examination, chest; single view <1% 295 $4K
90686 <1% 189 $3K
81002 <1% 2,360 $2K
80053 Comprehensive metabolic panel <1% 309 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,516 $2K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 1,360 $2K
73630 <1% 85 $2K
73030 <1% 76 $1K
90661 <1% 31 $930.19
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 14 $785.80
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 25 $703.22
G0008 Administration of influenza virus vaccine <1% 268 $556.68
87807 <1% 39 $400.11
82043 <1% 59 $260.06
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 287 $191.10
86308 <1% 24 $112.18
3078F <1% 10,351 $34.87
1125F <1% 7,202 $28.39
3074F <1% 8,477 $27.46
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 16 $23.96
1126F <1% 4,496 $19.68
3044F <1% 2,487 $10.58
3075F <1% 2,588 $9.74
3077F <1% 1,273 $4.44
3079F <1% 1,313 $4.35
3066F <1% 2,009 $2.59
3061F <1% 816 $1.64
3080F <1% 346 $1.11
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 14 $0.94
1160F <1% 12,179 $0.80
1159F <1% 10,643 $0.68
2022F <1% 20 $0.09
3072F <1% 19 $0.09
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 0% 368 $0.00
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 0% 3,504 $0.00
1101F 0% 9,013 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 0% 1,423 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 1,175 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 0% 2,105 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 0% 1,422 $0.00
1036F 0% 247 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.